Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity against mycobacteria.

Carol M Mason1, Juzar Ali

  • 1Division of Pulmonary/Critical Care Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. mason@lsuhsc.edu

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mycobacterium tuberculosis Infection After Grafting of Infected Bone: A Case Series of Four Patients.

Cureus·2024
Same author

Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension.

Pulmonary therapy·2024
Same author

Latent TB treatment regimens in 2023: Wetmore TB clinic in New Orleans.

Journal of clinical tuberculosis and other mycobacterial diseases·2024
Same author

Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.

American journal of respiratory and critical care medicine·2024
Same author

Aerosolized Liposomal Amikacin and Laryngeal Injury.

Chest·2021
Same author

A tale of two images: From mycobacterium avium complex-lung disease (MAC-LD) to mycobacterium avium complex-pleural disease.

Respiratory medicine case reports·2021
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Mycobacterium tuberculosis causes latent infections that can reactivate into active tuberculosis. This review discusses the immune response to tuberculosis and how the bacteria evade host defenses.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Mycobacterium tuberculosis is a leading global infectious agent.
  • Infection often results in persistent, non-replicating organisms (latent infection) despite host immunity.
  • Latent tuberculosis carries a risk of reactivation into active disease.

Purpose of the Study:

  • To review key features of the host immune response to mycobacteria.
  • To discuss mechanisms by which M. tuberculosis subverts host defenses.
  • To understand the persistence of M. tuberculosis despite host immunity.

Main Methods:

  • Literature review of immune responses to mycobacteria.
  • Analysis of mechanisms of immune evasion by M. tuberculosis.

Related Experiment Videos

Main Results:

  • Cell-mediated immunity is crucial but often insufficient for complete eradication.
  • M. tuberculosis persists in a latent state, evading immune surveillance.
  • The bacteria employ sophisticated strategies to subvert host immune defenses.

Conclusions:

  • Complete eradication of M. tuberculosis is frequently not achieved, even in immunocompetent hosts.
  • Understanding immune evasion mechanisms is critical for controlling tuberculosis.
  • M. tuberculosis persistence contributes significantly to the global tuberculosis epidemic.